Literature DB >> 26077053

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Cédric Bretonnière1, Marc Leone, Christophe Milési, Bernard Allaouchiche, Laurence Armand-Lefevre, Olivier Baldesi, Lila Bouadma, Dominique Decré, Samy Figueiredo, Rémy Gauzit, Benoît Guery, Nicolas Joram, Boris Jung, Sigismond Lasocki, Alain Lepape, Fabrice Lesage, Olivier Pajot, François Philippart, Bertrand Souweine, Pierre Tattevin, Jean-François Timsit, Renaud Vialet, Jean Ralph Zahar, Benoît Misset, Jean-Pierre Bedos.   

Abstract

Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimation de Langue Française (SRLF) and the Société Française d'Anesthésie et de Réanimation (SFAR) to set up a panel of experts from various disciplines. These experts met for the first time at the end of 2012 and have since met regularly to issue the following 67 recommendations, according to the rigorous GRADE methodology. Five fields were explored: i) the link between the resistance of bacteria and the use of antibiotics in intensive care; ii) which microbiological data and how to use them to reduce antibiotic consumption; iii) how should antibiotic therapy be chosen to limit consumption of antibiotics; iv) how can antibiotic administration be optimized; v) review and duration of antibiotic treatments. In each institution, the appropriation of these recommendations should arouse multidisciplinary discussions resulting in better knowledge of local epidemiology, rate of antibiotic use, and finally protocols for improving the stewardship of antibiotics. These efforts should contribute to limit the emergence of resistant bacteria.

Mesh:

Substances:

Year:  2015        PMID: 26077053     DOI: 10.1007/s00134-015-3853-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  95 in total

Review 1.  Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.

Authors:  Kenneth T Yu; Peter C Wyer
Journal:  Ann Emerg Med       Date:  2008-02-13       Impact factor: 5.721

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

Review 4.  Clinical management of Staphylococcus aureus bacteraemia.

Authors:  Guy E Thwaites; Jonathan D Edgeworth; Effrossyni Gkrania-Klotsas; Andrew Kirby; Robert Tilley; M Estée Török; Sarah Walker; Heiman Fl Wertheim; Peter Wilson; Martin J Llewelyn
Journal:  Lancet Infect Dis       Date:  2011-03       Impact factor: 25.071

5.  Utility of preliminary bronchoalveolar lavage results in suspected ventilator-associated pneumonia.

Authors:  Joseph M Swanson; G Christopher Wood; Martin A Croce; Eric W Mueller; Bradley A Boucher; Timothy C Fabian
Journal:  J Trauma       Date:  2008-12

6.  De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.

Authors:  Djamel Mokart; Géraldine Slehofer; Jérôme Lambert; Antoine Sannini; Laurent Chow-Chine; Jean-Paul Brun; Pierre Berger; Ségolène Duran; Marion Faucher; Jean-Louis Blache; Colombe Saillard; Norbert Vey; Marc Leone
Journal:  Intensive Care Med       Date:  2014-01       Impact factor: 17.440

7.  Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.

Authors:  Christina Routsi; Maria Pratikaki; Evangelia Platsouka; Christina Sotiropoulou; Vasileios Papas; Theodoros Pitsiolis; Athanassios Tsakris; Serafeim Nanas; Charis Roussos
Journal:  Intensive Care Med       Date:  2013-04-20       Impact factor: 17.440

8.  Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

Authors:  P Depuydt; D Benoit; D Vogelaers; J Decruyenaere; D Vandijck; G Claeys; G Verschraegen; S Blot
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

9.  Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.

Authors:  Pierre Charbonneau; Jean-Jacques Parienti; Pascal Thibon; Michel Ramakers; Cédric Daubin; Damien du Cheyron; Guy Lebouvier; Xavier Le Coutour; Roland Leclercq
Journal:  Clin Infect Dis       Date:  2006-02-07       Impact factor: 9.079

Review 10.  Ventilator-associated pneumonia: present understanding and ongoing debates.

Authors:  Girish B Nair; Michael S Niederman
Journal:  Intensive Care Med       Date:  2014-11-27       Impact factor: 17.440

View more
  21 in total

Review 1.  Focus on immunocompromised patients.

Authors:  Elie Azoulay; Marcio Soares; Dominique Benoit
Journal:  Intensive Care Med       Date:  2016-01-28       Impact factor: 17.440

2.  Does this patient have VAP?

Authors:  Jean Chastre; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2016-02-03       Impact factor: 17.440

3.  Rapid diagnostic test and use of antibiotic against methicillin-resistant Staphylococcus aureus in adult intensive care unit.

Authors:  A-F Dureau; G Duclos; F Antonini; D Boumaza; N Cassir; J Alingrin; C Vigne; E Hammad; L Zieleskiewicz; M Leone
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-07       Impact factor: 3.267

4.  What is the role of empirical treatment for suspected invasive candidiasis in non-neutropenic non transplanted patients in the intensive care unit?-Empiricus strikes back!

Authors:  Cédric Bretonnière; Karim Lakhal; Thierry Lepoivre; David Boutoille; Florent Morio
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

5.  Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-04-04       Impact factor: 17.440

6.  Focus on adequate antimicrobial treatment and de-escalation in the ICU.

Authors:  Dominique D Benoit; Gordon Doig; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2016-09-29       Impact factor: 17.440

7.  Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  François Barbier; Sébastien Bailly; Carole Schwebel; Laurent Papazian; Élie Azoulay; Hatem Kallel; Shidasp Siami; Laurent Argaud; Guillaume Marcotte; Benoît Misset; Jean Reignier; Michaël Darmon; Jean-Ralph Zahar; Dany Goldgran-Toledano; Étienne de Montmollin; Bertrand Souweine; Bruno Mourvillier; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2018-04-16       Impact factor: 17.440

8.  Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.

Authors:  Simon Poignant; Jérôme Guinard; Aurélie Guigon; Laurent Bret; Didier-Marc Poisson; Thierry Boulain; François Barbier
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

Review 9.  Quality indicators in intensive care medicine for Germany - third edition 2017.

Authors:  Oliver Kumpf; Jan-Peter Braun; Alexander Brinkmann; Hanswerner Bause; Martin Bellgardt; Frank Bloos; Rolf Dubb; Clemens Greim; Arnold Kaltwasser; Gernot Marx; Reimer Riessen; Claudia Spies; Jörg Weimann; Gabriele Wöbker; Elke Muhl; Christian Waydhas
Journal:  Ger Med Sci       Date:  2017-08-01

10.  Prevalence of MDR organism (MDRO) carriage in children and their household members in Siem Reap Province, Cambodia.

Authors:  Shweta R Singh; Bunsoth Mao; Konstantin Evdokimov; Pisey Tan; Phana Leab; Rick Ong; Saphonn Vonthanak; Clarence C Tam; Li Yang Hsu; Paul Turner
Journal:  JAC Antimicrob Resist       Date:  2020-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.